{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:03:16Z","timestamp":1792479796491,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371784"],"award-info":[{"award-number":["82371784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011441","name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Insight"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cellin.2025.100250","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:59:47Z","timestamp":1746727187000},"page":"100250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7862-1316","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6460-9427","authenticated-orcid":false,"given":"Alexander","family":"Filatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9858-7596","authenticated-orcid":false,"given":"Maria G.","family":"Byazrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellin.2025.100250_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coi.2018.10.007","article-title":"Lambda interferons come to light: Dual function cytokines mediating antiviral immunity and damage control","volume":"56","author":"Andreakos","year":"2019","journal-title":"Current Opinion in Immunology"},{"issue":"5","key":"10.1016\/j.cellin.2025.100250_bib2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cellin.2025.100250_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pulmoe.2021.03.008","article-title":"The immune response to SARS-CoV-2 and COVID-19 immunopathology-current perspectives","volume":"27","author":"Boechat","year":"2021","journal-title":"Pulmonology"},{"issue":"12","key":"10.1016\/j.cellin.2025.100250_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100833","article-title":"Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment","volume":"3","author":"Bosteels","year":"2022","journal-title":"Cell Reports Medicine"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib5","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1038\/s41467-020-19684-y","article-title":"STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters","volume":"11","author":"Boudewijns","year":"2020","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.cellin.2025.100250_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000863","article-title":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation","volume":"6","author":"Bouvet","year":"2010","journal-title":"PLoS Pathogens"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.cellin.2025.100250_bib8","article-title":"Pathophysiology of SARS-CoV-2: Targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response","author":"Bryce","year":"2020","journal-title":"The Mount Sinai COVID-19 autopsy experience"},{"issue":"6518","key":"10.1016\/j.cellin.2025.100250_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cellin.2025.100250_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: Immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nature Reviews Immunology"},{"issue":"4","key":"10.1016\/j.cellin.2025.100250_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12291-021-00967-0","article-title":"\u201cSilent hypoxemia\u201d leads to vicious cycle of infection, coagulopathy and cytokine storm in COVID-19: Can prophylactic oxygen therapy prevent it?","volume":"36","author":"Chauhan","year":"2021","journal-title":"Indian Journal of Clinical Biochemistry"},{"issue":"4","key":"10.1016\/j.cellin.2025.100250_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bj.2022.04.006","article-title":"SARS-CoV-2 variants--evolution, spike protein, and vaccines","volume":"45","author":"Chen","year":"2022","journal-title":"Biomedical Journal"},{"issue":"662","key":"10.1016\/j.cellin.2025.100250_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn5168","article-title":"A shift in lung macrophage composition is associated with COVID-19 severity and recovery","volume":"14","author":"Chen","year":"2022","journal-title":"Science Translational Medicine"},{"issue":"5","key":"10.1016\/j.cellin.2025.100250_bib14","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"Journal of Clinical Investigation"},{"issue":"10223","key":"10.1016\/j.cellin.2025.100250_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/v15030754","article-title":"Proinflammatory responses in SARS-CoV-2 and soluble spike glycoprotein S1 subunit activated human macrophages","volume":"15","author":"Chiok","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/IAI.00950-12","article-title":"Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth","volume":"81","author":"Chuquimia","year":"2013","journal-title":"Infection and Immunity"},{"issue":"4","key":"10.1016\/j.cellin.2025.100250_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/Glycolysis-Dependent Axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.cellin.2025.100250_bib20","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.23812\/20-1-E","article-title":"Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: A promising inhibitory strategy","volume":"34","author":"Conti","year":"2020","journal-title":"Journal of Biological Regulators & Homeostatic Agents"},{"key":"10.1016\/j.cellin.2025.100250_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","article-title":"Mapping the human genetic architecture of COVID-19","volume":"600","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cellin.2025.100250_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100144","article-title":"Development of SARS-CoV-2 entry antivirals","volume":"3","author":"Dong","year":"2024","journal-title":"Cell Insight"},{"issue":"15","key":"10.1016\/j.cellin.2025.100250_bib24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","article-title":"Bamlanivimab plus etesevimab in mild or moderate Covid-19","volume":"385","author":"Dougan","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.cellin.2025.100250_bib25","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","article-title":"Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells","volume":"73","author":"Fink","year":"2005","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01306-2022","article-title":"GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection","volume":"61","author":"Foo","year":"2023","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1016\/j.cellin.2025.100250_bib27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","article-title":"Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis","volume":"80","author":"Fu","year":"2020","journal-title":"Journal of Infection"},{"issue":"5","key":"10.1016\/j.cellin.2025.100250_bib28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","article-title":"Interferon-\u03bb mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness","volume":"46","author":"Galani","year":"2017","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cellin.2025.100250_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","article-title":"COVID-19-neutralizing antibodies predict disease severity and survival","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"7847","key":"10.1016\/j.cellin.2025.100250_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-020-03148-w","article-title":"Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia","volume":"590","author":"Grant","year":"2021","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.cellin.2025.100250_bib31","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib32","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/ijms23031716","article-title":"SARS-CoV-2-specific immune response and the pathogenesis of COVID-19","volume":"23","author":"Gusev","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","article-title":"Immunopathology of hyperinflammation in COVID-19","volume":"191","author":"Gustine","year":"2021","journal-title":"American Journal of Pathology"},{"issue":"15","key":"10.1016\/j.cellin.2025.100250_bib34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.2067","article-title":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS","volume":"210","author":"He","year":"2006","journal-title":"The Journal of Pathology"},{"issue":"10224","key":"10.1016\/j.cellin.2025.100250_bib36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(20)30374-3","article-title":"COVID-19: What is next for public health?","volume":"395","author":"Heymann","year":"2020","journal-title":"Lancet"},{"issue":"596","key":"10.1016\/j.cellin.2025.100250_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Science Translational Medicine"},{"issue":"10223","key":"10.1016\/j.cellin.2025.100250_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.cellin.2025.100250_bib39","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1002\/jmv.27917","article-title":"Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients","volume":"94","author":"Idiz","year":"2022","journal-title":"Journal of Medical Virology"},{"issue":"6","key":"10.1016\/j.cellin.2025.100250_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"7914","key":"10.1016\/j.cellin.2025.100250_bib41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cellin.2025.100250_bib42","first-page":"751","article-title":"A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein","volume":"13","author":"Kamitani","year":"2006","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/j.cellin.2025.100250_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33354","article-title":"IFN-\u03bb prevents influenza virus spread from the upper airways to the lungs and limits virus transmission","volume":"7","author":"Klinkhammer","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.cellin.2025.100250_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720109","article-title":"Monocytes and macrophages in COVID-19","volume":"12","author":"Knoll","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2025.100250_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-022-04576-6","article-title":"Whole-genome sequencing reveals host factors underlying critical COVID-19","volume":"607","author":"Kousathanas","year":"2022","journal-title":"Nature"},{"issue":"6532","key":"10.1016\/j.cellin.2025.100250_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib48","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/s41467-020-19943-y","article-title":"Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19","volume":"11","author":"Li","year":"2020","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100068","article-title":"Atlas of interactions between SARS-CoV-2 macromolecules and host proteins","volume":"2","author":"Li","year":"2023","journal-title":"Cell Insight"},{"issue":"6","key":"10.1016\/j.cellin.2025.100250_bib50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/j.cellin.2025.100250_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pccm.2023.10.003","article-title":"Mechanisms of long COVID: An updated review","volume":"1","author":"Liu","year":"2023","journal-title":"Chin. Med. J. Pulm. Crit. Care Med"},{"issue":"5","key":"10.1016\/j.cellin.2025.100250_bib52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41573-021-00154-z","article-title":"Channelling inflammation: Gasdermins in physiology and disease","volume":"20","author":"Liu","year":"2021","journal-title":"Nature Reviews Drug Discovery"},{"issue":"7","key":"10.1016\/j.cellin.2025.100250_bib53","first-page":"770","article-title":"SARS-CoV-2 is sensitive to type I interferon pretreatment","volume":"5","author":"Lokugamage","year":"2020","journal-title":"Nature Microbiology"},{"key":"10.1016\/j.cellin.2025.100250_bib54","article-title":"Monocytes and macrophages in COVID-19: Friends and foes","volume":"276","author":"Meidaninikjeh","year":"2021","journal-title":"Life Sciences"},{"issue":"12","key":"10.1016\/j.cellin.2025.100250_bib55","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib56","first-page":"5148","article-title":"SARS-CoV-2 ORF6 antagonizes interferon signaling by sequestering STAT1 and STAT2 in the endoplasmic reticulum","volume":"11","author":"Miorin","year":"2020","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2021.01.004","article-title":"Multi-organ proteomic landscape of COVID-19 autopsies","volume":"184","author":"Nie","year":"2021","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.cellin.2025.100250_bib58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.it.2022.08.001","article-title":"Afucosylated IgG responses in humans-structural clues to the regulation of humoral immunity","volume":"43","author":"Oosterhoff","year":"2022","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.cellin.2025.100250_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib60","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-021-25015-6","article-title":"SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.cellin.2025.100250_bib61","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type III interferons-induction, signaling, evasion, and application to combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host & Microbe"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1465-9921-6-75","article-title":"CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II","volume":"6","author":"Pechkovsky","year":"2005","journal-title":"Respiratory Research"},{"issue":"15","key":"10.1016\/j.cellin.2025.100250_bib63","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"10285","key":"10.1016\/j.cellin.2025.100250_bib64","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cellin.2025.100250_bib65","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib66","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41467-019-09397-2","article-title":"Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation","volume":"10","author":"Rogers","year":"2019","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.cellin.2025.100250_bib67","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Medicine"},{"issue":"23","key":"10.1016\/j.cellin.2025.100250_bib68","first-page":"2281","article-title":"Baricitinib is first approved COVID-19 immunomodulatory treatment","volume":"327","author":"Rubin","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cellin.2025.100250_bib69","author":"Schifanella"},{"issue":"6","key":"10.1016\/j.cellin.2025.100250_bib70","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1083\/jcb.201602089","article-title":"The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation","volume":"213","author":"Sharma","year":"2016","journal-title":"The Journal of Cell Biology"},{"issue":"2","key":"10.1016\/j.cellin.2025.100250_bib71","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cyto.a.24285","article-title":"Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages","volume":"103","author":"Song","year":"2023","journal-title":"Cytometry, Part A"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib72","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41392-022-01039-2","article-title":"Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants","volume":"7","author":"Sun","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"7918","key":"10.1016\/j.cellin.2025.100250_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-022-04865-0","article-title":"Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination","volume":"607","author":"Suryawanshi","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cellin.2025.100250_bib74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: Immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib76","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41467-023-37425-9","article-title":"TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques","volume":"14","author":"Upadhyay","year":"2023","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pccm.2024.02.005","article-title":"Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivors","volume":"2","author":"Wang","year":"2024","journal-title":"Chin. Med. J. Pulm. Crit. Care Med"},{"key":"10.1016\/j.cellin.2025.100250_bib79","article-title":"Alveolar macrophage activation and polarization in COVID-19: A systematic review of the current evidence","volume":"12","author":"Wang","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2020.07.005","article-title":"Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients","volume":"28","author":"Wang","year":"2020","journal-title":"Cell Host & Microbe"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib81","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41392-022-00977-1","article-title":"Airway administration of bisphosphate and dexamethasone inhibits SARS-CoV-2 variant infection by targeting alveolar macrophages","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"6501","key":"10.1016\/j.cellin.2025.100250_bib82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.cellin.2025.100250_bib83","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/JVI.80.10.5059-5064.2006","article-title":"Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses","volume":"80","author":"Weber","year":"2006","journal-title":"Journal of Virology"},{"issue":"7","key":"10.1016\/j.cellin.2025.100250_bib84","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1016\/j.cellin.2025.100250_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100145","article-title":"ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses","volume":"3","author":"Xiong","year":"2024","journal-title":"Cell Insight"},{"issue":"2","key":"10.1016\/j.cellin.2025.100250_bib86","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.2000513","article-title":"Inflammasomes and pyroptosis as therapeutic targets for COVID-19","volume":"205","author":"Yap","year":"2020","journal-title":"The Journal of Immunology"},{"issue":"10","key":"10.1016\/j.cellin.2025.100250_bib87","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-019-0182-z","article-title":"Interferon-\u03bb orchestrates innate and adaptive mucosal immune responses","volume":"19","author":"Ye","year":"2019","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib88","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2020.04.136","article-title":"Biochemical characterization of SARS-CoV-2 nucleocapsid protein","volume":"527","author":"Zeng","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"10.1016\/j.cellin.2025.100250_bib89","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/M20-0533","article-title":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19","volume":"172","author":"Zhang","year":"2020","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.cellin.2025.100250_bib90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pccm.2022.12.002","article-title":"Pulmonary fibrosis: A short-or long-term sequelae of severe COVID-19?","volume":"1","author":"Zheng","year":"2023","journal-title":"Chin. Med. J. Pulm. Crit. Care Med"},{"key":"10.1016\/j.cellin.2025.100250_bib91","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fimmu.2020.01061","article-title":"Interferon-\u03b12b treatment for COVID-19","volume":"11","author":"Zhou","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"10229","key":"10.1016\/j.cellin.2025.100250_bib92","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cellin.2025.100250_bib93","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41590-024-02072-9","article-title":"Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs","volume":"26","author":"Zhu","year":"2025","journal-title":"Nature Immunology"}],"container-title":["Cell Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892725000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892725000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:27:20Z","timestamp":1762648040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772892725000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2772892725000240"],"URL":"https:\/\/doi.org\/10.1016\/j.cellin.2025.100250","relation":{},"ISSN":["2772-8927"],"issn-type":[{"value":"2772-8927","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cell Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellin.2025.100250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Wuhan University.","name":"copyright","label":"Copyright"}],"article-number":"100250"}}